Sanner introduces bio-based plastic packaging
Represents the first biopackaging of its kind made of renewable raw materials.
At Pharmapack 2020, Sanner will focus on sustainability and will debut its new Sanner BioBase effervescent tablet packaging. Sanner BioBase is the first biopackaging of its kind made of renewable raw materials.
Sanner BioBase is the first effervescent tablet packaging that consists of more than 90% bio-based material. The biopolymers used consist of various renewable raw materials such as corn, sugar cane or cellulose, which are converted into "green" ethanol. A major advantage of bio-based plastic packaging is its essential independence from fossil raw material deposits and its reduced CO2 footprint. Bio-based plastic packaging has the same properties as conventional packaging solutions. They can also be processed on existing filling lines. From a chemical point of view, Sanner BioBase is almost identical to PE and PP from fossil raw materials.
High-quality and climate-friendly
"Sanner BioBase can be recycled, increases resource efficiency and makes it easier for us to achieve our climate targets," says Ursula Hahn, Head of Product Management at Sanner. Another important argument for customers and consumers is the extended shelf life of the tablets thanks to higher H2O barrier properties. In terms of handling, Sanner BioBase offers consumers a high-quality feel and appearance. The tablet tube can be printed or provided with an IML label.
Sanner BioBase will be commercially available from the second quarter of 2020. The initial tablet tube will have a diameter of 27 millimeters and can be combined with the appropriate desiccant closure. "The solution is currently aimed primarily at food supplement producers," says Ursula Hahn. "Due to the stricter regulations in the pharmaceutical industry, this market will be our next focus".
Sustainability and innovation as part of the corporate DNA
Sanner launched the first desiccant closure for moisture-sensitive tablets 60 years ago and became the market leader for both desiccant and effervescent tablet packaging. "We are continuing this tradition with continuous development work and with the first bio-based effervescent tablet packaging," says Peik-Christian Witte, Director R&D at Sanner. The company’s corporate culture is based on innovation and sustainability: Sanner has been investing in the optimization of its own manufacturing processes for many years. For example, the Bensheim site uses its own combined heat and power generation system. In recent years, the company has been able to significantly reduce CO2 emissions and energy consumption for the production of plastic packaging.
TabTec CR tablet container: child-resistant and senior-friendly
Also on show at Pharmapack: the TabTec CR tablet container, which was launched at the end of 2019 and will also be showcased in the Pharmapack Innovation Gallery. The innovative opening mechanism protects children from accidentally taking painkillers, antidepressants or medical cannabis. The patented Press & Flip closure prevents opening by children's hands. However, it is easy to handle for adults and especially for seniors by pressing and simultaneously folding up the closure. The desiccant integrated into the bottom of the container and the appropriate color selection protect the contents from moisture and light at all times. The integrated pouring assistance ensures hygienic and easy dosing of the drugs.Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance